Evidence map›Paper›PMID 18084691›Full record

Trial reportOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2008

Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.

D von Mühlen, G A Laughlin, D Kritz-Silverstein, J Bergstrom, R Bettencourt

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00664053 (Effects of DHEA/Exercise on Bone, Muscle and Balance), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00664053 phase4completednot on this map

Effects of DHEA/Exercise on Bone, Muscle and Balance

TypeinterventionalSponsorNational Aeronautics and Space Administration (NASA)Ran2004 to 2006Enrolled99ConditionsOsteoporosis, FrailtyArmsDHEA, Yoga, Placebo, Aerobics
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Should Dehydroepiandrosterone Be Administered to Women?The Journal of clinical endocrinology and metabolism · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Sex steroid actions in male bone.Endocrine reviews · 2014
    Review
  17. Review
  18. Review
  19. Article
  20. Osteoporosis in men.Nature reviews. Endocrinology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

D von MühlenDepartment of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA 92093-0631, USA. dvonmuhlen@ucsd.edu
G A Laughlin
D Kritz-Silverstein
J Bergstrom
R Bettencourt
University of California, San Diego · US

Funding

ZOVIRAX CREAM TO TREAT HERPES LABIALIS IN ADOLESCENTSM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, R JEFFREY · 1985 to 2010
$74.3M
DHEA REPLACEMENT IN HEALTHY OLDER MEN AND WOMENR01AG018339 · NIA · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI VON MUHLEN, DENISE GOLDANI · 2000 to 2004
$2.5M
NCRR NIH HHS M01 RR000827NCRR NIH HHS M01 RR00827NIA NIH HHS AG018339NIA NIH HHS R01 AG018339
6 · The paper itself

Abstract

unlabelledWe present results of a randomized, placebo-controlled trial to examine the effect of 50 mg daily oral DHEA supplementation for one year on bone mineral density (BMD), bone metabolism and body composition in 225 healthy adults aged 55 to 85 years.

introductionDehydroepiandrosterone (DHEA) levels decline dramatically with age, concurrent with the onset of osteoporosis, suggesting a role for DHEA supplementation in preventing age-related bone loss.

methodsWe conducted a randomized, placebo-controlled trial to examine the effect of 50 mg daily oral DHEA supplementation for one year on bone mineral density (BMD), bone metabolism and body composition in 225 healthy adults aged 55 to 85 years.

resultsDHEA treatment increased serum DHEA and DHEA sulfate levels to concentrations seen in young adults. Testosterone, estradiol and insulin-like growth factor (IGF-1) levels increased in women (all p < 0.001), but not men, receiving DHEA. Serum C-terminal telopeptide of type-1 collagen levels decreased in women (p = 0.03), but not men, whereas bone-specific alkaline phosphatase levels were not significantly altered in either sex. After 12 months, there was a positive effect of DHEA on lumbar spine BMD in women (p = 0.03), but no effect was observed for hip, femoral neck or total body BMD, and no significant changes were observed at any site among men. Body composition was not affected by DHEA treatment in either sex.

conclusionAmong older healthy adults, daily administration of 50 mg of DHEA has a modest and selective beneficial effect on BMD and bone resorption in women, but provides no bone benefit for men.

Indexed as

AgedAged, 80 and overBiomarkersBody CompositionBone DensityBone Density Conservation AgentsBone RemodelingDehydroepiandrosteroneFemaleHumansMaleMiddle AgedOsteoporosisTestosteroneBiomarkersBone Density Conservation AgentsDehydroepiandrosteroneTestosterone

Identifiers

PMID18084691
PMCPMC2435090
OpenAlexW1969373921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.